[PDF][PDF] Minimal residual disease monitoring in chronic myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation using interphase …

HQ Zhu, XL Liu, LL Song, QF Liu, FY Meng… - Chin J …, 2010 - scholar.archive.org
… During the treatment for CML, it is necessary to conduct a dynamic monitoring on tumor
burden, so as to modify treatment scheme and achieve a complete cytogenetic remission (CCR, …

[HTML][HTML] 苯所致慢性髓性白血病5 例临床分析

詹昱, 杨志前, 曲佳, 冯可欣, 杨郁青, 谭明珠… - 职业卫生与应急 …, 2021 - oher.com.cn
… 获完全细胞遗传学反应(complete cytogenetic response,CCyR),12个月时… chronic myelogenous
leukemia(CML)caused by benzene, so as to strengthen prevention and standard treatment

Arsenic-containing qinghuang powder (青黄散) is an alternative treatment for elderly acute myeloid leukemia patients refusing low-intensity chemotherapy

T Fan, R Quan, W Liu, H Xiao, X Tang, C Liu… - Chinese journal of …, 2020 - Springer
… At the initial diagnosis, 27 patients were tested for cytogenetics. The … treat patients with
myeloid leukemia for approximately 50 year-old , as well as those with chronic myeloid leukemia (…

[HTML][HTML] … Comments Off on The US FDA has issued full approval for Israeli drugmaker Teva's Synribo (omacetaxine mepesuccinate) 高三尖杉酯碱for chronic myeloid …

OFT BLOG - allfordrugs.com
… the treatment of adult patients with chronic myeloid leukemia (… resistant T315I mutation
achieved cytogenetic response in 28… The present new method uses a special biochemical agent …

[HTML][HTML] RDW 对初诊慢性粒细胞白血病慢性期患者TKI 治疗反应的早期预测价值

胡金花, 徐子瑶, 孙倩, 刘文洁, 洪鸣… - 南京医科大学学报(自然 …, 2022 - jnmu.njmu.edu.cn
… Early molecular and cytogenetic response is predictive for longterm … at diagnose is a simple
negative prognostic factor in chronic phase⁃chronic myeloid leukemia patients treated with …

荧光原位杂交技术在异基因造血干细胞移植监测中的作用**★

莫耀禧, 周瑞莲, 莫伟英, 蓝梅, 林金盈 - 中国组织工程研究, 2012 - cjter.com
… Molecular cytogenetic monitoring of chimerism and minimal residual disease in patient with
chronic myeloid leukemia after allogenic and syngenic bone marrow transplantation.Ter Arkh…

[PDF][PDF] 早幼粒细胞白血病分子遗传学诊疗技术在临床中的应用

宋鹏, 张鑫, 赵海岳, 佟菲, 周晋 - 现代生物医学进展, 2012 - biomed.cnjournals.com
Methods: We tested chromosomal abnormalities in bone marrow samples from 83 patients
with … Cytogenetic dynamic detection in chronic myeloid leukemia in application [J]. Journal of …

Relation of blood arsenic concentration with effect and safety of arsenic-containing Qinghuang Powder (青黄散) in patients with myelodysplastic syndrome

Z Deng, S Zhu, M Wang, S Fang, P Zhao, Q Zhu… - Chinese journal of …, 2019 - Springer
myeloid leukemia cells progressed from MDS,(13-16) which might explain one of the
mechanisms of QHP in the treatment … with other karyotypes, based on cytogenetics. As well as, …

造血干细胞移植治疗地中海贫血

吴学东, 井远方, 温建芸, 刘华颖, 王彦华, 李春富 - 中国组织工程研究, 2012 - cjter.com
… Evolving concepts in the management of chronic myeloid leukemia: recommendations from
… Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl …

[PDF][PDF] 分子生物学在血液病诊断和治疗中的应用及研究进展

史美玉, 唐诗哲, 徐挺亮, 周凯燕… - Progress in Modern …, 2020 - biomed.cnjournals.com
… The application of molecular biological methods in the diagnosis and … oncoprint of
recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia[J]. …